Intelligent Bio Solutions (INBS) revenue and earnings history
Intelligent Bio Solutions reported revenue of $4.22M for fiscal 2026 (year ended Jun 30, 2026), +38.1% on the year before, and net income of −$12.4M.
Over 6 years, from fiscal 2020 to fiscal 2026, revenue grew at a compound rate of +67.8% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026ended Jun 30, 2026 | $4.22M+38.1% | −$12.6M | −$12.4M | −$11.9M | $126K | −$12.1M | $195K | — | — | $3.99M | — | 10-K |
| 2025ended Jun 30, 2025 |
The latest quarter, insider trades and fund moves: Intelligent Bio Solutions (INBS) on OQRO.
Common questions
What was Intelligent Bio Solutions's revenue in fiscal 2026?
$4.22M for the year ended Jun 30, 2026, as reported in its 10-K filed Aug 19, 2026. That is +38.1% on fiscal 2025 ($3.05M).
How fast has Intelligent Bio Solutions's revenue grown?
From $189K in fiscal 2020 to $4.22M in fiscal 2026: a compound annual growth rate of +67.8% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Intelligent Bio Solutions tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.